FDA approves Ionis' Zanvastro, first treatment for Alexander disease

The FDA approved Ionis' Zanvastro, the first disease-modifying therapy for Alexander disease, a rare and fatal neurological disorder. This marks a significant regulatory milestone for Ionis and offers a new treatment option for a previously untreatable condition. The approval's impact on patient outcomes and commercial uptake remains to be seen.